SCHEMBL4898294

SCHEMBL4898294

CCN(c1nc2cc(Cl)ccc2o1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C1R P00736 2/20 0.49
PRSS1 P07477 2/20 0.49
LMNA P02545 3/20 0.43
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
GAA P10253 3/20 0.41
KCNH2 Q12809 2/20 0.41
HPGD P15428 2/20 0.41
ALDH1A1 P00352 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
FBP1 P09467 2/20 0.41
THRB P10828 1/20 0.40
ANO1 Q5XXA6 1/20 0.39
AGPAT2 O15120 1/20 0.39
PARP3 Q9Y6F1 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 1/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905642 0.90 C1R (0.49) C1RPRSS1LMNAMEN1KMT2A
SCHEMBL4903840 0.90 HPGD (0.47) C1RPRSS1LMNAMEN1KMT2A
SCHEMBL4902746 0.90 ALDH1A1 (0.45) C1RPRSS1LMNAMEN1KMT2A
SCHEMBL4896007 0.89 C1R (0.46) C1RPRSS1LMNAMEN1KMT2A
SCHEMBL4904839 0.88 C1R (0.49) C1RPRSS1LMNAMEN1KMT2A
SCHEMBL4904431 0.87 C1R (0.45) C1RPRSS1LMNAMEN1KMT2A
SCHEMBL4899819 0.87 C1R (0.51) C1RPRSS1LMNAMEN1KMT2A
SCHEMBL4894363 0.87 PRSS1 (0.40) C1RPRSS1LMNAMEN1KMT2A
SCHEMBL5716848 0.83 CASP3 (0.42) PRSS1LMNAMEN1KMT2AGAA
SCHEMBL4899200 0.82 ALDH1A1 (0.45) C1RPRSS1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD C1R 4367/4885PRSS1 1105/4885LMNA 319/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD C1R 4367/4885PRSS1 1105/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.